Alnylam Competitors and Similar CompaniesClear all

Celyad's competitors and similar companies include Moderna, CureVac, Regulus Therapeutics, Sarepta Therapeutics and Ionis Pharmaceuticals.
Celyad
Celyad
Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.
Moderna
Moderna
Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.
CureVac
CureVac
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.
Sarepta Therapeutics
Sarepta Therapeutics
Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases.
Ionis Pharmaceuticals
Ionis Pharmaceuticals
Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
Founding Date
Founding Date
2007
Founding Date
2010
Founding Date
2000
Founding Date
2007
Founding Date
1980
Founding Date
1989
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Mont-Saint-Guibert, BE HQ
New York, US
Locations
Cambridge, US HQ
Melbourne, AU
Paris, FR
München, DE
Tokyo, JP
Seoul, KR
Warszawa, PL
see more
Locations
Tübingen, DE HQ
Ottignies Louvain La Neuve, BE
Wiesbaden, DE
Amsterdam, NL
Basel, CH
Boston, US
Locations
San Diego, US HQ
Locations
Cambridge, US HQ
Dublin, IE
Zug, CH
Providence, US
Locations
Carlsbad, US HQ
Employees
Employees
17
Employees
5,60044% increase
Employees
999
Employees
2462% decrease
Employees
1,31413% increase
Employees
92716% increase
Valuation ($)
Valuation ($)
12.1 m
Valuation ($)
21.2 b
Valuation ($)
648.3 m
Valuation ($)
105.4 m
Valuation ($)
12.4 b
Valuation ($)
6.2 b

Financial

Revenue (est.)
Revenue (est.)
€102k (FY, 2023)
Revenue (est.)
$6.8b (FY, 2023)
Revenue (est.)
€53.8m (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
$1.2b (FY, 2023)
Revenue (est.)
$787.6m (FY, 2023)
Cost of goods
Cost of goods
€69k (FY, 2023)
Cost of goods
$4.7b (FY, 2023)
Cost of goods
€64.3m (FY, 2023)
Cost of goods
N/A
Cost of goods
$150.3m (FY, 2023)
Cost of goods
$9.1m (FY, 2023)
Gross profit
Gross profit
€1.4m (FY, 2023)
Gross profit
$2.2b (FY, 2023)
Gross profit
(€2.6m) (FY, 2023)
Gross profit
N/A
Gross profit
$1.1b (FY, 2023)
Gross profit
$778.5m (FY, 2023)
Net income
Net income
(€8.4m) (FY, 2023)
Net income
($4.7b) (FY, 2023)
Net income
(€260.2m) (FY, 2023)
Net income
($30m) (FY, 2023)
Net income
($536m) (FY, 2023)
Net income
($366.3m) (FY, 2023)

Operating

Patent Applications
Patent Applications
N/A
Patent Applications
430 (FY, 2021)
Patent Applications
500 (Mar, 2020)
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
N/A
Patents Issued
Patents Issued
N/A
Patents Issued
270 (FY, 2020)
Patents Issued
233 (May, 2020)
Patents Issued
300 (FY, 2016)
Patents Issued
N/A
Patents Issued
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
3 (May, 2020)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
1 (FY, 2023)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 1.8b
Total funding raised
$ 1.1b
Total funding raised
$ 10m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Moderna
HQ
Cambridge, US
Employees
5,600↑ 44% increase

Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.

View company
CureVac
HQ
Tübingen, DE
Employees
999

CureVac is a biotechnology company offering messenger RNA (mRNA) technology.

View company
Regulus Therapeutics
HQ
San Diego, US
Employees
24

Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.

View company
Sarepta Therapeutics
HQ
Cambridge, US
Employees
1,314↑ 13% increase

Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases.

View company